: Suppliers use Healthcare Common Procedure Coding System (HCPCS) code Q2052 for home administration services. Market and Cost Overview (Assumed 2024–2026)
: Periodic shortages have been reported by the FDA due to increased demand and plasma supply chain stress. Requirements for Coverage
: As of January 1, 2024, Medicare Part B provides a permanent benefit for the supplies and services needed to receive IVIG at home for patients with PI.
: Medicare payment amounts for administration services (Q2052) have seen annual increases, with the 2025 allowable amount reported at $431.83.
: These are the primary sources for IVIG. They coordinate with your doctor to deliver the medication to your home or an infusion center.
Recent legislative changes have significantly expanded how patients "buy" and receive IVIG at home:
Billing and Coding: Immune Globulin Intravenous (IVIg) - CMS
: The U.S. IVIG market was valued at approximately $5.74 billion in 2022 and is projected to grow through 2030 due to increased demand for replacement therapies.